These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20513406)

  • 41. A pathway of structural changes produced by monastrol binding to Eg5.
    Maliga Z; Xing J; Cheung H; Juszczak LJ; Friedman JM; Rosenfeld SS
    J Biol Chem; 2006 Mar; 281(12):7977-82. PubMed ID: 16434397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of ncd to microtubules induces a conformational change near the junction of the motor domain with the neck.
    Naber N; Cooke R; Pate E
    Biochemistry; 1997 Aug; 36(32):9681-9. PubMed ID: 9245400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of the kinesin neck linker and catalytic core in microtubule-based motility.
    Case RB; Rice S; Hart CL; Ly B; Vale RD
    Curr Biol; 2000 Feb; 10(3):157-60. PubMed ID: 10679326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5.
    Kozielski F; Skoufias DA; Indorato RL; Saoudi Y; Jungblut PR; Hustoft HK; Strozynski M; Thiede B
    Proteomics; 2008 Jan; 8(2):289-300. PubMed ID: 18186019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms.
    Liu L; Parameswaran S; Liu J; Kim S; Wojcik EJ
    J Biol Chem; 2011 Feb; 286(8):6201-10. PubMed ID: 21127071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eg5 Inhibitors Have Contrasting Effects on Microtubule Stability and Metaphase Spindle Integrity.
    Chen GY; Kang YJ; Gayek AS; Youyen W; Tüzel E; Ohi R; Hancock WO
    ACS Chem Biol; 2017 Apr; 12(4):1038-1046. PubMed ID: 28165699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insights into the Molecular Mechanisms of Eg5 Inhibition by (+)-Morelloflavone.
    Ogunwa TH; Laudadio E; Galeazzi R; Miyanishi T
    Pharmaceuticals (Basel); 2019 Apr; 12(2):. PubMed ID: 30995725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conformational change of the loop L5 in rice kinesin motor domain induced by nucleotide binding.
    Umeki N; Mitsui T; Kondo K; Maruta S
    J Biochem; 2006 May; 139(5):857-64. PubMed ID: 16751593
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and dynamics of the force-generating domain of myosin probed by multifrequency electron paramagnetic resonance.
    Nesmelov YE; Agafonov RV; Burr AR; Weber RT; Thomas DD
    Biophys J; 2008 Jul; 95(1):247-56. PubMed ID: 18339764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The marine natural product adociasulfate-2 as a tool to identify the MT-binding region of kinesins.
    Brier S; Carletti E; DeBonis S; Hewat E; Lemaire D; Kozielski F
    Biochemistry; 2006 Dec; 45(51):15644-53. PubMed ID: 17176086
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ESR reveals the mobility of the neck linker in dimeric kinesin.
    Sugata K; Nakamura M; Ueki S; Fajer PG; Arata T
    Biochem Biophys Res Commun; 2004 Feb; 314(2):447-51. PubMed ID: 14733926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
    Maliga Z; Kapoor TM; Mitchison TJ
    Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single-molecule observations of neck linker conformational changes in the kinesin motor protein.
    Tomishige M; Stuurman N; Vale RD
    Nat Struct Mol Biol; 2006 Oct; 13(10):887-94. PubMed ID: 17013387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinctions between dynamic characteristics of the single EG5 motor protein along neural vs. cancerous microtubules.
    Feizabadi MS; Jun Y; Reddy JN
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1630-3. PubMed ID: 27590585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
    DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
    Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allosteric control of kinesin's motor domain by tubulin: a molecular dynamics study.
    Krukau A; Knecht V; Lipowsky R
    Phys Chem Chem Phys; 2014 Apr; 16(13):6189-98. PubMed ID: 24561904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A structural model for monastrol inhibition of dimeric kinesin Eg5.
    Krzysiak TC; Wendt T; Sproul LR; Tittmann P; Gross H; Gilbert SP; Hoenger A
    EMBO J; 2006 May; 25(10):2263-73. PubMed ID: 16642039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Morelloflavone as a novel inhibitor of mitotic kinesin Eg5.
    Ogunwa TH; Taii K; Sadakane K; Kawata Y; Maruta S; Miyanishi T
    J Biochem; 2019 Aug; 166(2):129-137. PubMed ID: 30785183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Getting in sync with dimeric Eg5. Initiation and regulation of the processive run.
    Krzysiak TC; Grabe M; Gilbert SP
    J Biol Chem; 2008 Jan; 283(4):2078-87. PubMed ID: 18037705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.
    Ogo N; Oishi S; Matsuno K; Sawada J; Fujii N; Asai A
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3921-4. PubMed ID: 17524640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.